| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NBIX over the last quarter tilts toward selling: insiders offloaded a net 5,291 shares worth roughly $826K.
Classified under Pharmaceuticals (Health Care sector), NBIX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 517.8K | $80.89M | - | |
| CEO | 154.7K | $24.17M | - | |
| Dir | 122.1K | - | - | |
| Other | 67.3K | - | - | |
| Other | 56.8K | $8.87M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | Boyer David W.51 | Chief Corp. Affairs Officer | Sell10b5-1 | 826 | $157.45 | $130,050.56 | -8.7% | - | - | |
| Sep 14, 2026 | Abernethy Matt57 | Chief Financial Officer | Sell10b5-1 | 2,311 | $157.20 | $363,284.81 | -5.1% | - | - | |
| Sep 9, 2026 | Benevich Eric62 | Chief Commercial Officer | Sale+OE10b5-1 | 2,154 | $154.61 | $333,029.94 | -3.2% | - | - | |
| Jul 28, 2026 | Norwalk Leslie V64 | Director | Sale+OE10b5-1 | 1,250 | $182.01 | $227,507.50 | -44.0% | -21.9% | - | |
| Jul 10, 2026 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE10b5-1 | 4,367 | $181.02 | $790,514.34 | -21.2% | -20.2% | - | |
| Jul 9, 2026 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE10b5-1 | 10,000 | $179.60 | $1,796,014.00 | -15.4% | -20.5% | - | |
| Jul 9, 2026 | Delaet Ingrid66 | Chief Regulatory Officer | Sale+OE10b5-1 | 14,571 | $178.65 | $2,603,111.99 | -47.3% | -20.5% | - | |
| Jun 29, 2026 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE10b5-1 | 10,000 | $170.15 | $1,701,492.09 | -15.4% | -17.4% | - | |
| Jun 5, 2026 | Sherwin Stephen A | Director | Sale+OE10b5-1 | 25,000 | $165.32 | $4,132,968.88 | -61.2% | -3.4% | - | |
| Jun 4, 2026 | Norwalk Leslie V64 | Director | Sell10b5-1 | 1,250 | $168.06 | $210,071.63 | -30.6% | -5.7% | - |